{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:38:38Z","timestamp":1740155918501,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41585-020-00378-5","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T12:03:09Z","timestamp":1600084989000},"page":"609-610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimizations to keep gonorrhoea treatable and reduce antimicrobial resistance selection"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1710-2081","authenticated-orcid":false,"given":"Magnus","family":"Unemo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"378_CR1","unstructured":"World Health Organization. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. WHO https:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241503501\/en\/ (2012)."},{"key":"378_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1071\/SH19023","volume":"16","author":"M Unemo","year":"2019","unstructured":"Unemo, M. et al. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts. Sex. Health 16, 412\u2013425 (2019).","journal-title":"Sex. Health"},{"key":"378_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41572-019-0128-6","volume":"5","author":"M Unemo","year":"2019","unstructured":"Unemo, M. et al. Gonorrhoea. Nat. Rev. Dis. Primers. 5, 79 (2019).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"378_CR4","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1016\/S1473-3099(20)30171-7","volume":"20","author":"AC Se\u00f1a","year":"2020","unstructured":"Se\u00f1a, A. C. et al. Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction. Lancet Infect. Dis. 20, e181\u2013e191 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"378_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237424","volume":"15","author":"C Ferreyra","year":"2020","unstructured":"Ferreyra, C. et al. Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: an expert consensus. PLoS ONE 15, e0237424 (2020).","journal-title":"PLoS ONE"},{"key":"378_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/14737159.2017.1360137","volume":"17","author":"V Don\u00e0","year":"2017","unstructured":"Don\u00e0, V., Low, N., Golparian, D. & Unemo, M. Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae. Expert Rev. Mol. Diagn. 17, 845\u2013859 (2017).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"378_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa596","author":"JD Klausner","year":"2020","unstructured":"Klausner, J. D. et al. Resistance-guided treatment of gonorrhea: a prospective clinical study. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa596 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"378_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/OLQ.0000000000000591","volume":"44","author":"L-T Allan-Blitz","year":"2017","unstructured":"Allan-Blitz, L.-T., Wang, X. & Klausner, J. D. Wild-type gyrase A genotype of Neisseria gonorrhoeae predicts in vitro susceptibility to ciprofloxacin: a systematic review of the literature and meta-analysis. Sex. Transm. Dis. 44, 261\u2013265 (2017).","journal-title":"Sex. Transm. Dis."},{"key":"378_CR9","doi-asserted-by":"crossref","unstructured":"Unemo, M. et al. 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. Int. J. STD AIDS (in the press).","DOI":"10.1177\/0956462420949126"},{"key":"378_CR10","unstructured":"Hadad, R. et al. Evaluation of the SpeeDx ResistancePlus\u00ae GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance\/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae. J. Antimicrob. Chemother. (in the press)."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-020-00378-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-020-00378-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-020-00378-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T23:23:40Z","timestamp":1631575420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-020-00378-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["378"],"URL":"https:\/\/doi.org\/10.1038\/s41585-020-00378-5","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"type":"print","value":"1759-4812"},{"type":"electronic","value":"1759-4820"}],"subject":[],"published":{"date-parts":[[2020,9,14]]},"assertion":[{"value":"14 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}